MARTINA, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 4.246
AS - Asia 1.654
EU - Europa 1.564
SA - Sud America 390
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 127
OC - Oceania 5
Totale 8.124
Nazione #
US - Stati Uniti d'America 4.160
SG - Singapore 505
VN - Vietnam 371
IT - Italia 350
RU - Federazione Russa 320
CN - Cina 315
BR - Brasile 307
HK - Hong Kong 179
IE - Irlanda 156
SE - Svezia 147
FR - Francia 134
DE - Germania 103
UA - Ucraina 96
GB - Regno Unito 67
CI - Costa d'Avorio 62
IN - India 59
FI - Finlandia 54
BD - Bangladesh 52
TR - Turchia 39
CA - Canada 34
MX - Messico 30
AR - Argentina 27
JP - Giappone 27
NL - Olanda 27
DK - Danimarca 26
PL - Polonia 22
ZA - Sudafrica 21
ES - Italia 20
KR - Corea 19
MA - Marocco 19
IQ - Iraq 16
AT - Austria 15
EC - Ecuador 13
VE - Venezuela 13
PK - Pakistan 12
BE - Belgio 11
ID - Indonesia 11
CL - Cile 8
CO - Colombia 8
PH - Filippine 8
PY - Paraguay 7
UZ - Uzbekistan 6
AU - Australia 5
SA - Arabia Saudita 5
TN - Tunisia 5
CU - Cuba 4
CZ - Repubblica Ceca 4
HN - Honduras 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
GT - Guatemala 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
IL - Israele 2
LT - Lituania 2
NG - Nigeria 2
NI - Nicaragua 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
OM - Oman 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
TW - Taiwan 1
Totale 7.987
Città #
Ashburn 701
Dallas 401
Chandler 367
Des Moines 324
Singapore 310
San Jose 237
Council Bluffs 186
Hong Kong 173
Dublin 146
New York 143
Boardman 129
Ho Chi Minh City 120
Fairfield 117
Jacksonville 102
Hanoi 101
The Dalles 79
Los Angeles 78
Beijing 69
Lauterbourg 65
Abidjan 61
Wilmington 59
Lawrence 53
Princeton 53
Seattle 53
Woodbridge 53
Houston 46
Moscow 44
Milan 42
Munich 41
Cambridge 38
Centro 35
San Mateo 34
Santa Clara 33
São Paulo 28
Buffalo 27
Turin 26
London 24
San Diego 23
Turku 23
Hefei 22
Phoenix 22
Tokyo 21
Orem 20
Rome 20
Washington 20
Guangzhou 19
Helsinki 19
Warsaw 19
Da Nang 18
Atlanta 15
Chicago 15
Denver 15
Haiphong 15
Columbus 14
Redmond 14
Ancona 13
Johannesburg 13
Pune 13
Shanghai 13
Boston 12
Frankfurt am Main 12
Rio de Janeiro 12
Toronto 12
Ann Arbor 11
Baghdad 10
Brooklyn 10
Chennai 10
Stockholm 10
Curitiba 9
Mexico City 9
Montreal 9
Pesaro 9
San Francisco 9
Urbisaglia 9
Brussels 8
Miano 8
Wuhan 8
Brasília 7
Mumbai 7
Norwalk 7
Vienna 7
Amsterdam 6
Florence 6
Kolkata 6
Kyiv 6
Philadelphia 6
Bắc Ninh 5
Charlotte 5
Guarulhos 5
Guayaquil 5
Hải Dương 5
Jiaxing 5
Kazan' 5
Maracaibo 5
Poplar 5
Quito 5
Thái Nguyên 5
Belo Horizonte 4
Biên Hòa 4
Buenos Aires 4
Totale 5.286
Nome #
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 223
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 194
Adalimumab modulates angiogenesis in psoriatic skin 176
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 174
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 159
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 153
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 151
Activated switched memory B cell clusters in chronic spontaneous urticaria are increased in subjects with long disease duration and relapse upon omalizumab discontinuation: Results of the IL-10-OMZ study 147
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 146
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 146
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 145
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 145
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 144
Skin Involvement in SARS-CoV-2 Infection: Case Series 140
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 138
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 135
"BOTULINUM TOXIN IN DERMATOLOGY: A CLINICAL OVERVIEW" 135
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 134
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 133
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? 133
Primary cutaneous large cell lymphoma CD30+: a case-based review 132
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 131
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 131
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 130
Hidradenitis suppurativa: How to treat with BoNT-A 129
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 128
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 127
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 127
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study 126
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 125
Asymptomatic pigmentation of the skin in a child: babywipes, once again 125
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 124
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 124
Photoprotection and photodermatitis: a case 123
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 123
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 122
Botulinum Toxin Off-Label Use in Dermatology: A Review 121
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 121
Safety update of etanercept treatment for moderate to severe plaque psoriasis 120
Topical application of fumaric acid esters improves appearance of nail psoriasis 119
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 118
Iperidrosi focale: novità terapeutiche 114
Acral Leukoderma: Is It Always Vitiligo? 114
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 111
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 109
Role of small intestinal bacterial overgrowth and helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis 105
Modern electronic devices: An increasingly common cause of skin disorders in consumers 102
It is never too late to treat chronic spontaneous urticaria with omalizumab: Real-life data from a multicenter observational study focusing on elderly patients 98
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 97
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 96
Myroxylon pereirae (balsam of Peru): Still worth testing? 94
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness 93
Omalizumab in Chronic Urticaria: An Italian Survey. 93
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 93
Saliva and Oral Diseases 90
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 90
Mesenchymal Stem Cells and Psoriasis: Systematic Review 89
Contact allergy to hydrocortisone 21-acetate in Italy: A SIDAPA multicenter study 88
Hand eczema in Italian patients referred for patch testing: A retrospective SIDAPA study (2016–2023) 86
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage 86
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 78
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 76
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 74
Preliminary experience with abrocitinib in severe atopic dermatitis 70
The pharmacological treatment and management of hyperhidrosis 68
Translation and pre-validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ) in Italian 63
The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going 63
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 57
Treatment of Axillary Bromhidrosis with Topical 2% Glycopyrronium Bromide Cream: A Prospective, Non-randomized, Open-label Study 50
Totale 8.124
Categoria #
all - tutte 39.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022345 0 0 12 2 35 15 9 31 23 12 121 85
2022/20231.180 78 119 63 97 52 419 0 48 204 5 77 18
2023/2024604 86 11 58 66 86 172 10 16 6 20 11 62
2024/20251.241 150 92 22 26 41 30 103 46 308 86 169 168
2025/20263.640 306 211 379 293 399 210 624 290 314 334 111 169
2026/2027323 151 126 46 0 0 0 0 0 0 0 0 0
Totale 8.124